Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.0001 (100.00%)
Jul 31, 2025, 1:07 PM EDT

Endonovo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 20182014 - 2018
Period Ending
Jul '25 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2014 - 2018
031027
Upgrade
Market Cap Growth
255.39%211.36%127.79%-74.11%-74.55%-57.10%
Upgrade
Enterprise Value
-11871115
Upgrade
Last Close Price
0.000.020.020.021.9018.20
Upgrade
PS Ratio
0.9425.8415.372.986.1489.88
Upgrade
PB Ratio
-0.01-0.11-0.07-0.03-0.09-0.66
Upgrade
EV/Sales Ratio
-79.16107.9239.7434.81182.79
Upgrade
Debt / Equity Ratio
-0.31-0.22-0.45-0.46-0.42-0.69
Upgrade
Asset Turnover
0.230.080.030.060.080.02
Upgrade
Quick Ratio
-00.010.000.000.03
Upgrade
Current Ratio
0.0000.010.000.000.03
Upgrade
Return on Assets (ROA)
-144.27%-124.08%-60.32%-61.89%-63.34%-58.72%
Upgrade
Earnings Yield
-1825.00%-528.17%-276.38%-80.21%-908.97%-86.00%
Upgrade
FCF Yield
--19.41%-87.82%-150.37%-133.53%-38.59%
Upgrade
Buyback Yield / Dilution
-130.88%-132.64%-389.83%-1651.87%-92.38%-49.72%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.